AlphAIAlphAI — Financial news for AI agents
manilatimes.netJUL 33 min read$REE

REE Automotive Announces Receipt of Nasdaq Delisting Notice

REE Automotive (Nasdaq: REE) said Nasdaq notified it of a delisting determination after the company failed to regain compliance with Nasdaq’s $1.00 minimum bid price rule (Rule 5550(a)(2)) during an additional 180-day period ending June 29, 2026. Trading of its Class A ordinary shares will be suspended July 7, 2026, and Nasdaq will file Form 25-NSE.

Original reporting
manilatimes.net
Published Jul 3, 2026, 7:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 3, 2026, 7:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
REE Automotive Announces Receipt of Nasdaq Delisting Notice — source image
Source · manilatimes.net
Decision brief

The 30-second read

$REEBearishHigh
01

Why it matters

Nasdaq’s delisting determination means REE’s shares will be suspended on July 7, 2026, and Nasdaq will file Form 25-NSE to remove the securities from listing/registration.

02

Market read

This is a direct, time-bound listing event that can materially change trading liquidity, spreads, and risk premia for REE.

03

What to watch

The article doesn’t quantify expected OTC liquidity, potential reverse-split plans, or any parallel financing/strategic actions that could offset delisting risk.

Relevance 9/10Novelty 9/10Timing: ahead of the July 7, 2026 Nasdaq trading suspension

Background

REE previously failed Nasdaq’s $1.00 minimum bid price requirement for 30 consecutive business days, received an initial 180-day period, then an additional 180-day extension.

Company-level read

Ticker impact

$REEBearishHigh confidence
Context

REE received a Nasdaq delisting determination and its Class A ordinary shares will be suspended from trading on July 7, 2026.

Expected impact

Near-term downside pressure is likely into the July 7 suspension, with elevated volatility as liquidity and listing risk worsen.

Evidence & confidence

The article discloses a concrete exchange action (delisting determination, suspension date, and intent not to request a hearing), which typically drives immediate risk repricing.

Market effects

Sector

Signals heightened listing-risk sensitivity for small-cap/early-stage automotive tech names reliant on maintaining minimum bid price compliance.

Regional

Primarily impacts US-listed Israeli tech equities; may spill into sentiment for similar cross-listed microcaps.

Global

Limited broader global impact, but reinforces exchange compliance as a key risk factor for international issuers on Nasdaq.

Counterpoint

What could challenge this read

Some delisted names can continue trading on other venues (e.g., OTC) and may see stabilization if investors expect a path to regain compliance or restructure.

Key entities

  • public_company
    REE Automotive Ltd.

    Nasdaq-listed automotive technology company receiving the delisting determination and scheduling a July 7, 2026 suspension.

  • regulator_exchange
    Nasdaq Stock Market LLC

    Exchange authority issuing the delisting determination under Listing Rule 5550(a)(2).

Read at source← All news

Related articles

JUL 10
$CEROHighAI 8/10

Delisting of Securities from The Nasdaq Stock Market

Nasdaq said it will delist multiple issuers’ securities from the Nasdaq Stock Market, including CERo Therapeutics Holdings, Bowen Acquisition Corp, Graphjet Technology, Blue Hat Interactive Entertainment Technology, X3 Holdings Co, Captivision Inc, Actelis Networks, American Rebel Holdings, Reviva Pharmaceuticals, Alchemy Investments Acquisition Corp 1, Bitcoin Depot, Inotiv, GoHealth, Functional Brands, Sleep Number, Smart Digital Group, and REE Automotive. Most were suspended in 2025-2026 and

manilatimes.net4 min
OCT 28
$ECORMed

electroCore submits FDA 510(k) application for CIPN device

electroCore (NASDAQ:ECOR) submitted a 510(k) application to the FDA for its Quell device to treat chemotherapy-induced peripheral neuropathy (CIPN). The submission is based on two studies showing pain score reductions and improvements in neuropathy symptoms. FDA clearance is not guaranteed, and Quell is not currently approved for CIPN.

investing.com4 min
OCT 28
$ECORMed

electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)

electroCore, Inc. (ECOR) submitted a 510(k) premarket notification to the FDA seeking clearance for its Quell® device to treat chronic chemotherapy-induced peripheral neuropathy (CIPN). The submission is supported by clinical studies showing symptom improvements. If cleared, Quell would be among the first FDA-cleared devices for CIPN. The FDA review process is underway, with no guarantee of clearance.

globenewswire.com4 min
OCT 28
$PVLAMedAI 8/10

FDA grants priority review to Palvella’s lymphatic malformation therapy

Palvella Therapeutics (NASDAQ:PVLA) announced FDA Priority Review for QTORIN 3.9% gel to treat microcystic lymphatic malformations, with a target action date of February 28, 2027. The application is based on positive Phase 3 SELVA study results, showing significant efficacy and a good safety profile. The therapy has received Breakthrough Therapy, Fast Track, and Orphan Drug designations. Palvella plans a potential U.S. launch in early 2027, pending approval.

investing.com3 min
OCT 28
$GOOGLMed

South Korea fined Google and Apple 63.7 billion won over app payments

South Korea's regulator fined Google and Apple 63.7 billion won for restricting app payment options. The companies were accused of forcing developers to use in-app billing tools with high fees. Both firms must now allow third-party payment links and adjust their fee structures. They have three months to comply. According to the regulator, Apple charged developers higher commissions in South Korea than in other markets.

qz.com4 min